Are there registered clinical trials specifically testing a product called gelatide?
Executive summary
A review of the provided reporting finds no evidence of registered clinical trials that specifically test a commercial product named “Gelatide”; the product’s own marketing and third‑party reviews acknowledge an absence of published clinical trials on the finished formulation [1] [2] [3]. There are, however, numerous legitimate clinical trials and product offerings that involve gelatin or gelatine capsules as delivery vehicles, and unrelated trials whose names (e.g., GELATO) could be confused with the brand name [4] [5] [6] [7].
1. No registry entry or published trial identified for “Gelatide”
Investigative signals from the product’s own official site and contemporary reviews state that Gelatide’s formulation “lacks published clinical trials” validating the complete ingredient combination, explicitly flagging an absence of formal evidence on the marketed product itself [1], and independent product coverage repeats that the company offers no FDA evaluation or published clinical data for the supplement [2] [3]. The reporting supplied does not include a ClinicalTrials.gov record or other registry entry that lists a trial of a product named “Gelatide” [8]; therefore, based on the sources provided, there are no documented registered clinical trials specifically testing a product called Gelatide.
2. Related science exists—gelatine/gelatin capsules and probiotic trials are different things
The literature and industry pages in the record show legitimate clinical research and commercial products that use gelatin or gelatine as a capsule material or delivery system, such as over-encapsulation capsules designed for blinded clinical studies (ACGcaps™ GC, DBcaps®, FM-CAPS®) and clinical trials of gelatine‑encapsulated probiotic formulations [5] [6] [9] [4]. Those citations demonstrate clinical use of gelatine as a dosage form or vehicle, but they do not constitute evidence that a branded supplement called Gelatide has undergone a registered efficacy or safety trial; the distinction between a capsule material and a branded multi‑ingredient supplement is central and repeatedly reflected in the sources [5] [4] [6].
3. Name collisions and plausible confusion—GELATO vs. Gelatide
Searchable trial names and acronyms can mislead: for example, the GELATO trial is an oncology immunotherapy study unrelated to any dietary supplement and focused on lobular breast cancer, a separate context that could be mistaken for the product name in casual searches [7]. The supplied materials caution readers that many capsule‑related terms and trial acronyms exist in the registry and literature, so lack of an exact match for “Gelatide” in the reporting should not be conflated with absence of clinical research using gelatine as a delivery form [7] [5] [6].
4. Manufacturer claims and the limits of available reporting
Gelatide’s marketing and affiliated reviews expressly state the company does not have published clinical trials on the combined product formula [1] [2] [3]; those admissions are strong evidence within the provided record that no peer‑reviewed or registry‑listed trials for the brand were available to reporters. That said, the available sources do not include a comprehensive search of global registry databases beyond the materials shown here, so absence of evidence in these snippets cannot be proven to be definitive beyond the scope of the supplied reporting [8] [1].
5. Bottom line and recommended next steps for verification
Based on the documents provided, there are no registered clinical trials specifically testing a product called Gelatide and the product’s own materials and third‑party analyses acknowledge a lack of published clinical evidence for the finished supplement [1] [2] [3]; to move from reasonable reporting to definitive confirmation, a targeted search of ClinicalTrials.gov, the EU Clinical Trials Register, and WHO ICTRP for the exact trade name and company sponsor would be the appropriate next step—actions that are not represented in the present source set [8].